Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics. Mishra A, Kumar D, Gupta K, Lofland G, et al. Clin Cancer Res 2023;29:581-591.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mishra A, Kumar D, Gupta K, Lofland G, et al. Gallium-68-labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics. Clin Cancer Res 2023;29:581-591.
PMID: 36449662